This convergence suggests that OSA risk may operate through interconnected pathways crucial for T cell activation, including mitochondrial regulation (TUFM), cytoskeletal dynamics (MAST3, FNBP4), and transcriptional control (SGF29, SH3YL1). The gene discussed is SGF29; the disease is obstructive sleep apnea syndrome.